You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
川寧生物(301301.SZ):目前所生產的合成生物學產品紅沒藥醇等產品已用於化粧品製作
格隆匯 08-21 13:29

格隆匯8月21日丨有投資者向川寧生物(301301.SZ)提問,“2022年以來,以華熙為代表的眾多生物科技公司致力於探索以合成生物學為底層技術,生產製造用於美粧、護膚、醫美領域的生物活性原料。請問貴公司合成生物技術發展如何?生產的紅沒藥醇、紅景天苷能否用於生產化粧品、醫美領域、保健品?比如面膜、眼霜,口紅、防脱洗髮水等,今年原料的銷量如何?公司是否有醫美方面的規劃佈局?”

川寧生物回覆稱,公司目前已有多個合成生物學項目進入中試階段,公司首個合成生物學項目紅沒藥醇已進入銷售階段。公司目前所生產的合成生物學產品紅沒藥醇等產品已用於化粧品製作。關於原料藥的銷量請您關注公司近期披露的公司半年報。公司合成生物學未來產品領域將圍繞保健品原料、生物農藥、高附加值天然產物、高端化粧品原料等領域進行佈局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account